Search for Clinical Trial Results
Nephritis - 213 Studies Found
Status | Study |
Recruiting |
Study Name: Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis Condition:
Date: 2014-02-12 Interventions:
|
Active, not recruiting |
Study Name: Eculizumab in Primary MPGN Condition: Membranoproliferative Glomerulonephritis Date: 2014-03-17 Interventions: Drug: Eculizumab Other Name: Soliris |
Completed |
Study Name: Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic Nephropathy Condition:
Date: 2009-06-03 Interventions: Drug: olmesartan medoxomil olmesartan medoxomil tablets, once daily |
Not yet recruiting |
Study Name: Daratumumab in Treatment of PGNIMD and C3 GN Condition: Membranoproliferative Glomerulonephritis Date: 2017-03-20 Interventions: Drug: Daratumumab Open-label Other Name: Darzalex |
Completed |
Study Name: Effects of Systemic NO-Inhibition on Renal Hemodynamics in Patiens With Polycystic Kidney Disease and Chronic Glomerulonephritis Condition:
Date: 2006-06-24 Interventions: Drug: Ng-monomethyl-L-arginine (drug) |
Completed |
Study Name: A Dose Escalation Study of Long-acting ACTH Gel in Membranous Nephropathy Condition: Glomerulonephritis Date: 2010-03-24 Interventions: Drug: Adrenocorticotrophic hormone ACTH There will be two arms to the study: one arm receive 40 units an |
Completed |
Study Name: Autonomic Nervous System (ANS) and Renal Function in Immunoglobin A (IgA) Nephropathy Condition: IGA Glomerulonephritis Date: 2015-08-18 Interventions: Device: Holter measure of ANS in IgAN patients |
Completed |
Study Name: Pilot Study of Enalapril and Renal Function in Patients With IgA Nephropathy Condition: IGA Glomerulonephritis Date: 2000-08-03 Interventions: Drug: enalapril |
Completed |
Study Name: Alternate Day Prednisone or Daily Fish Oil Supplements in Patients With Immunoglobulin A Nephropathy Condition: IGA Glomerulonephritis Date: 1999-10-18 Interventions:
|
Completed |
Study Name: Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor Condition: Glomerulonephritis Date: 2007-02-20 Interventions: Drug: Ramipril 2.5mg and increase to 5mg if patient do not develop symptomatic hypotension |